• ONWARD Medical reported the first implant in its EIGER clinical feasibility study of the investigational ARC-IM implanted stimulation system.
• Safety and early signs of benefit will be assessed; no results have been presented yet.
• Study targets recovery of standing and walking in people with subacute spinal cord injury or chronic spinal cord injury.
• Enrollment set at up to 12 participants in Switzerland; data intended to guide the design of a future pivotal trial.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ONWARD Medical NV published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609030130OMX_____CNEWS_EN_GNW9820672_en) on September 03, 2026, and is solely responsible for the information contained therein.